Matthew Winkler
Director/Board Member at AKOYA BIOSCIENCES, INC.
Net worth: 4 M $ as of 30/04/2024
Profile
Matthew M.
Winkler was the founder of Ambion, Inc. (founded in 1988) where he served as the Chief Executive Officer from 2010 to 2016.
He was also the founder of Mirna Therapeutics, Inc. (founded in 2007) where he held the position of Independent Director.
Additionally, he was the founder of Asuragen, Inc. (founded in 2006) where he served as Chairman.
Dr. Winkler currently holds multiple positions.
He is the Director at The Breakthrough Institute since 2017.
He is also an Independent Director at Akoya Biosciences, Inc., Director at Revive & Restore, and Director at Genetic Literacy Project, all since 2017.
In his former roles, Dr. Winkler served as a Director at Second Genome, Inc. He also worked as an Associate Professor at The University of Texas at Austin from 1983 to 1991.
Dr. Winkler pursued his undergraduate and doctorate degrees at the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AKOYA BIOSCIENCES INC
1.99% | 31/03/2024 | 984,513 ( 1.99% ) | 4 M $ | 30/04/2024 |
Matthew Winkler active positions
| Companies | Position | Start |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | Director/Board Member | 01/07/2017 |
| The Breakthrough Institute | Director/Board Member | 01/01/2017 |
| Revive & Restore | Director/Board Member | 01/01/2017 |
| Genetic Literacy Project | Director/Board Member | 01/01/2017 |
Former positions of Matthew Winkler
| Companies | Position | End |
|---|---|---|
Ambion, Inc.
 Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | Chief Executive Officer | 01/03/2016 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Director/Board Member | 01/03/2016 |
| The University of Texas at Austin | Corporate Officer/Principal | 01/01/1991 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Founder | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Founder | - |
Training of Matthew Winkler
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Ambion, Inc.
Ambion, Inc. Pharmaceuticals: MajorHealth Technology Ambion, Inc. develops and supplies RNA based life science research and molecular biology products. It specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA. The company was founded in November 1988 and is headquartered in Austin, TX | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
| Akoya Biosciences, Inc. | |
| The Breakthrough Institute | |
| Revive & Restore | |
| Genetic Literacy Project |
- Stock Market
- Insiders
- Matthew Winkler
